Multi-scale Simulations of Bronic Acids in Prteasome Inhibition and Saccharide

布朗酸在蛋白酶体抑制和糖中的多尺度模拟

基本信息

  • 批准号:
    8811251
  • 负责人:
  • 金额:
    $ 24.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-10 至 2017-01-31
  • 项目状态:
    已结题

项目摘要

The candidate earned a Ph.D. in chemistry from the University of Georgia working under the direction of Henry F. Schaefer, Graham-Perdue Professor of Chemistry. Research performed during graduate school focused on the application of quantum mechanical (QM) methods to determine thermodynamic, spectroscopic, and structural properties of silicon and aluminum complexes. This graduate work led to the identification of highly accurate methods for use in specific molecular systems and has continued through post-doctoral training. The candidate's post-doctoral work has further extended his expertise in QM computations to boron containing molecules that rely on specific approaches due to their unique chemistry. The proposed computations will build on the candidate's background in QM methodology and provide new experience in methods to study larger macromolecules. The Research Plan will investigate the chemistry governing boronic acid (BA) based proteasome inhibition and saccharide sensing. Boronic acids have emerged as important chemical structures for use in a number of potential medical and biological applications. Chemical interactions related to these fields will be studied with the following: Mixed Quantum Mechanical/Molecular Mechanical (QM/MM) methods and mathematical modeling of reaction pathways accessed via the new Multi-Scale interface implemented in the CHARMM software suite of programs. These methods represent a new field of study for the candidate and will broaden his expertise significantly. Specifically, these computations will investigate BA based inhibition of proteasomes. Despite their promise in the treatment of a myriad of cancers, this inhibitory effect is not fully understood. Furthermore, there is an increase in chemoresistance of the only FDA approved proteasome inhibitor, Bortezoniib (a dipeptidyl-boronic acid). Determining the cause of this increased resistance and the chemical interactions of BAs in the binding pocket will provide valuable insight for future proteasome inhibitors. Three possible reasons for this resistance will be explored. These include: (1) understanding the chemical reactions for the metabolism of bortezomib, (2) adverse reactions through conjugation therapy from supplements that oxidize bortezomib, and (3) the potential inhibition of glutathionyl spermidine synthase that may potentially cause an increase in glutathione, a known target of resistance suppressing conjugates. Boronic acids have also been shown to be excellent synthetic fluorescent markers for saccharides. This proposal also plans to use QM/MM methods to understand the chemical interactions of boronic acid-sugar complexes in an attempt to develop saccharide specific sensors in a modular fashion. Results will be used to design synthetic receptors for the identification of sugar units in glycans that are representative of disease states. The Career Development Award will aid the candidate in mastering the necessary tools for these studies through continued training in the Laboratory of Computational Biology within the NlH/NHLBl. Previous postdoctoral research focused on highly accurate computation of chemical properties of smaller boronic acid model systems using QM only approaches. This award will facilitate a transition into multiple length scale (Multi- Scale) QM/MM modeling using reaction pathway techniques not currently in the candidate's repertoire. Multi- Scale simulations represent a highly significant, new area of study that bridge many computational disciplines. This award will help to establish the candidate as a leader in this new field. Additional practical experience will include the ability to modify, through computer programming, the complex computer program CHARMM. In addition to being a comprehensive biological modeling platform, CHARMM also serves as a repository for the newest algorithms in the field of computational biology and chemistry. The candidate will gain valuable experience by refining and advancing reaction path methodology during the award period. In addition to research training, further education during the award period will consist of attending grant-writing workshops and biology focused classes offered through the Office of Intramural Training and Education (OITE) at the NIH. The candidates Advisory Committee will meet annually to discuss progress and to ensure that the proposed goals are met, making recommendations where needed. Weekly meetings with the candidate's mentor will also be invaluable. This support will keep the candidate on track to successfully transition to an independent research position.
候选人获得了博士学位。佐治亚大学在亨利的指导下工作的化学学士学位 F. Schaefer,Graham-Perdue化学教授。研究生院期间进行的研究专注于 量子机械(QM)方法的应用来确定热力学,光谱和 硅和铝制复合物的结构特性。这项研究生的工作导致了高度识别 在特定分子系统中使用的准确方法,并通过博士后训练继续进行。这 候选人的博士后工作进一步扩展了他在QM计算中的专业知识 由于其独特的化学作用,分子依赖于特定方法。 拟议的计算将以QM方法的候选人背景为基础,并提供新的 有研究较大大分子的方法的经验。研究计划将调查化学 基于硼酸(BA)的蛋白酶体抑制和糖含量。硼酸具有 出现在许多潜在的医学和生物学应用中,成为重要的化学结构。 与这些领域相关的化学相互作用将通过以下研究:混合量子 机械/分子机械(QM/mm)方法和反应途径的数学建模 通过在CHARMM软件套件中实现的新的多尺度接口访问。这些 方法代表了候选人的新研究领域,并将大大扩大他的专业知识。 具体而言,这些计算将研究基于BA的抑制蛋白酶体。尽管他们承诺 对无数癌症的治疗,这种抑制作用尚未完全理解。此外,还有一个 唯一获得FDA批准的蛋白酶体抑制剂Bortezoniib的化学耐药性增加 酸)。确定这种增加的电阻的原因以及BAS在结合中的化学相互作用 口袋将为未来的蛋白酶体抑制剂提供宝贵的见解。这种抵抗的三个可能原因 将被探索。其中包括:(1)了解硼替佐米代谢的化学反应,(2) 通过氧化硼替佐米的补充剂结合治疗的不良反应,(3)潜力 抑制谷胱甘肽精子素合酶可能会导致谷胱甘肽的增加,这是已知的 抑制偶联物的抗性目标。 硼酸也已证明是糖的极好的合成荧光标记。这 建议还计划使用QM/mm方法来了解硼酸糖的化学相互作用 复合物是试图以模块化方式开发糖水的特定传感器。结果将用于 设计合成受体,用于鉴定代表疾病的聚糖中的糖单元 国家。 职业发展奖将帮助候选人掌握这些研究的必要工具 通过在NLH/NHLBL内的计算生物学实验室进行培训。以前的博士后 研究侧重于高度准确的较小硼酸模型的化学性质计算 仅使用QM方法的系统。该奖项将促进过渡到多长度量表(多数 比例)使用当前未在候选人曲目中的反应途径技术进行QM/MM建模。多- 比例模拟代表了一个非常重要的新研究领域,该领域弥合了许多计算学科。 该奖项将有助于将候选人确立为这个新领域的领导者。其他实用经验将 包括通过计算机编程,复杂的计算机程序CHARMM修改的能力。在 除了成为一个全面的生物建模平台外,Charmm还充当了 计算生物学和化学领域的最新算法。候选人将获得宝贵的 通过完善和推进奖励期间的反应路径方法的经验。 除了研究培训外,奖励期间的进一步教育还将包括参加赠款写作 通过壁内培训和教育办公室(OETE)提供的研讨会和生物学以班级为中心 在NIH。候选人咨询委员会将每年开会,讨论进步并确保 实现了建议的目标,在需要时提出建议。与候选人的每周会议 导师也将是无价的。这种支持将使候选人能够成功地过渡到 独立研究职位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Dennis Larkin其他文献

Joseph Dennis Larkin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Dennis Larkin', 18)}}的其他基金

Multi-scale Simulations of Bronic Acids in Prteasome Inhibition and Saccharide
布朗酸在蛋白酶体抑制和糖中的多尺度模拟
  • 批准号:
    8837057
  • 财政年份:
    2014
  • 资助金额:
    $ 24.9万
  • 项目类别:

相似海外基金

Advanced Preclinical Testing of a Broad-Spectrum Antiparasitic Quinolones for Veteran Health
广谱抗寄生虫喹诺酮类药物对退伍军人健康的高级临床前测试
  • 批准号:
    10265392
  • 财政年份:
    2019
  • 资助金额:
    $ 24.9万
  • 项目类别:
Advanced Preclinical Testing of a Broad-Spectrum Antiparasitic Quinolones for Veteran Health
广谱抗寄生虫喹诺酮类药物对退伍军人健康的高级临床前测试
  • 批准号:
    10454872
  • 财政年份:
    2019
  • 资助金额:
    $ 24.9万
  • 项目类别:
Advanced Preclinical Testing of a Broad-Spectrum Antiparasitic Quinolones for Veteran Health
广谱抗寄生虫喹诺酮类药物对退伍军人健康的高级临床前测试
  • 批准号:
    9891845
  • 财政年份:
    2019
  • 资助金额:
    $ 24.9万
  • 项目类别:
Structural Basis for Antiviral Drug Mitochondrial Toxicity
抗病毒药物线粒体毒性的结构基础
  • 批准号:
    10356145
  • 财政年份:
    2018
  • 资助金额:
    $ 24.9万
  • 项目类别:
Multi-scale Simulations of Bronic Acids in Prteasome Inhibition and Saccharide
布朗酸在蛋白酶体抑制和糖中的多尺度模拟
  • 批准号:
    8837057
  • 财政年份:
    2014
  • 资助金额:
    $ 24.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了